Search results for "Antidepressants"


 
Results 1 - 10 of about 165 for "Antidepressants".
Sort by: Relevance | Newest | Oldest

MKSAP Quiz: 6-month history of low back pain

A 58-year-old man is evaluated for a 6-month history of persistent low back pain. The patient is a postal employee who first developed pain after lifting a heavy mailbag onto a truck. The pain is localized to the lumbar back, is bilateral, and does not radiate. After review of a previous MRI and a physical exam, what is the most appropriate treatment?
https://immattersacp.org/weekly/archives/2024/05/14/3.htm
14 May 2024

Everyday symptoms could point to potential PTSD

A clinical practice guideline can help clinicians screen for, diagnose, and treat post-traumatic stress disorder (PTSD) and a related condition, acute stress disorder.
https://immattersacp.org/archives/2024/05/everyday-symptoms-could-point-to-potential-ptsd.htm
1 May 2024

Antidepressant data show only small improvement over placebo, meta-analysis finds

A recent analysis looked at 232 randomized, double-blind, placebo-controlled trials of drug monotherapy for major depressive disorder submitted by drug developers to the FDA between 1979 and 2016.
https://immattersacp.org/weekly/archives/2022/08/09/5.htm
9 Aug 2022

Sorting out vertigo

A shift in diagnostic approach for vertigo involves asking about the timing and triggers for episodes rather than a description of symptoms.
https://immattersacp.org/archives/2024/01/sorting-out-vertigo.htm
1 Jan 2024

Most antidepressants ineffective for common pain conditions, review finds

The systematic review found no high-certainty evidence supporting the effectiveness of antidepressants for pain, and the only moderate-certainty evidence was for serotonin-norepinephrine reuptake inhibitors to treat back pain, postoperative pain, neuropathic pain, and fibromyalgia.
https://immattersacp.org/weekly/archives/2023/02/07/1.htm
7 Feb 2023

ACP's updated depression guideline recommends CBT, second-generation antidepressants

ACP stressed the importance of informing patients and taking their preferences into account when deciding between the recommended first-line therapies of cognitive behavioral therapy (CBT) or an antidepressant.
https://immattersacp.org/weekly/archives/2023/01/24/1.htm
24 Jan 2023

Updated advice on anxiety screening

The U.S. Preventive Services Task Force recently concluded that for adults up to age 65 years, including those who are pregnant or postpartum, screening for anxiety is beneficial and should be conducted routinely in primary care.
https://immattersacp.org/archives/2023/10/updated-advice-on-anxiety-screening.htm
1 Oct 2023

Anxiety, depression treatment linked with improved outcomes in cardiovascular disease

Patients who had been hospitalized and had both cardiovascular disease and a mental health condition were 75% less likely to be readmitted if they received psychotherapy and medication for their anxiety or depression.
https://immattersacp.org/weekly/archives/2024/03/26/4.htm
26 Mar 2024

A living guideline for depression treatment

ACP recommends choosing between a second-generation antidepressant or cognitive behavioral therapy for adults in the acute phase of moderate to severe major depressive disorder.
https://immattersacp.org/archives/2023/06/a-living-guideline-for-depression-treatment.htm
1 Jun 2023

Antidepressants associated with decreased mortality rates in patients with diabetes and depression

A retrospective cohort study in Taiwan found that antidepressant use was associated with a significantly reduced risk for death, and after adjustment, total mortality decreased as total cumulative antidepressant dose increased.
https://immattersacp.org/weekly/archives/2019/07/09/4.htm
9 Jul 2019

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next